Free Trial

Immunovant (IMVT) SEC Filings & 10K Form

Immunovant logo
$14.80 -0.38 (-2.47%)
As of 03:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Immunovant SEC Filings

DateFilerForm TypeView
08/11/2025
6:29 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2025
6:14 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2025
4:56 PM
Immunovant (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
4:10 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
4:11 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:02 PM
Immunovant (Subject)
Macias William L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2025
4:34 PM
Immunovant (Subject)
Macias William L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2025
4:42 PM
Immunovant (Subject)
Macias William L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2025
6:14 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2025
6:30 AM
Immunovant (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/21/2025
3:24 PM
Immunovant (Subject)
MIGAUSKY GEORGE V (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
6:30 PM
Immunovant (Issuer)
Susman Robert Graham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
6:30 PM
Bauer Jake (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
6:30 PM
Girao Tiago (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
4:01 PM
Immunovant (Issuer)
Susman Robert Graham (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/28/2025
4:02 PM
Bauer Jake (Reporting)
Immunovant (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/28/2025
4:03 PM
Girao Tiago (Reporting)
Immunovant (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/21/2025
6:18 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2025
6:54 AM
Immunovant (Subject)
Roivant Sciences Ltd. (Filed by)
Roivant Sciences Ltd. (Filed by)
Form SCHEDULE 13D/A
04/17/2025
3:07 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
3:08 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:50 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:51 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:53 PM
Gloria Melanie (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:55 PM
Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:41 PM
Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:43 PM
Hughes Douglas J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:44 PM
Immunovant (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:46 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:48 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:37 PM
Immunovant (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
6:51 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
3:18 PM
Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:17 PM
Fromkin Andrew J. (Reporting)
Immunovant (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
9:01 AM
FMR LLC (Filed by)
Immunovant (Subject)
Form SCHEDULE 13G/A
02/06/2025
5:45 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/06/2025
5:37 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
4:20 PM
Immunovant (Filer)
Form 424B3
01/24/2025
4:24 PM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
3:22 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.tc pixel

Click here to see why Tesla's about to prove everyone wrong... again.
01/24/2025
3:23 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
4:16 PM
Immunovant (Filer)
Form D
Notice of Exempt Offering of Securities 
01/15/2025
3:36 PM
Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:30 PM
Immunovant (Subject)
Roivant Sciences Ltd. (Filed by)
Roivant Sciences Ltd. (Filed by)
Form SCHEDULE 13D/A
01/14/2025
7:09 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:07 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
4:01 PM
Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2024
4:02 PM
Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:11 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:12 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:09 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:08 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
4:11 PM
Gloria Melanie (Reporting)
Immunovant (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2024
4:15 PM
Gloria Melanie (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
5:42 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
5:49 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
3:21 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:23 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:25 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:27 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:28 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:30 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:31 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
6:40 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMVT) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners